2022 ACA Phoenix Program Book_Winter Conference

B-1E The Evolution of HIV Treatment and 340b Programs (CE, CME) Room 127A Track: Healthcare This presentation will provide a multidisciplinary overview of the evolution of HIV/AIDS treatment from its discovery as a new disease in 1981 until today. Concurrently, we will provide an overview of how the 340b drug program evolved as the need for funding treatment became more important over time. Learning Objectives: • Address HIV/AIDS health care in a prison setting. • Identify the evolution of HIV/AIDS treatment from 1981 to today. • Explain the evolution of the 340b program to help defray the cost of treatment of HIV/ AIDS. Moderator: Thomas Reimers , Health Services Director, Florida Department of Corrections, Tallahassee, Florida Speakers: Thomas Reimers , Health Services Director, Florida Department of Corrections, Tallahassee, Florida; Florida; Trey Fuller , PharmD, Assistant Director of Health Services, Virginia Department of Corrections, Richmond, Virginia; Danny Martinez , M.D., MPH, Chief of Medical Services, Florida Department of Corrections, Tallahassee, Florida B-1F Implementation of Interferon-Gamma Release Assay Testing for Management of Tuberculosis within the Inmate Population (CE, CME) Room 127B Track: Healthcare The Tennessee Department of Correction (TDOC) has developed guidelines for reducing the risk of transmitting M. Tuberculosis to employees and inmates alike. TDOC works closely with the Tennessee Department of Health to ensure continuity of care for those individuals are diagnosed with active or latent TB. During this discussion, we will look at Interferon-Gamma Release Assay testing, why it is considered a better form of testing, and the advantages to utilizing this test specifically

Workshops

Friday, Jan. 7 t 8:30–10 a.m.

for the inmate population. We will review TDOC’s guidelines for Tuberculosis screening from the intake process to yearly screenings. We will also explore the process from collection to receiving the results and discuss treatment options based on those results. Learning Objectives: • Identify the inmates that will require IGRA testing. • Report on the process of IGRA testing. • Explain the process of treatments based on the results of the IGRA. Moderator: Brenda J. Boyd , RN, Director of Clinical Support, Tennessee Department of Corrections, Nashville, Tennessee Speakers: Sarah Burnett , RN, Statewide Health Educator, Tennessee Department of Corrections, Nashville, Tennessee; Jennifer Derrick , RN, Statewide Infection Control Coordinator, Tennessee Department of Corrections, Nashville, Tennessee

ACA 2022 Winter Conference — 71